---
title: "Endocrine Society Launches Diabetes SIG and Expands Education, Research, Advocacy"
id: "endocrine-news-1-society-offers-full-spectrum-of-diabetes-resources-including-a-new-sig-for"
canonical_url: "https://medichelpline.com/clinical-feed/endocrine-news-1-society-offers-full-spectrum-of-diabetes-resources-including-a-new-sig-for"
content_type: "clinical_feed_article"
specialty: "Endocrinology"
source_name: "Endocrine News"
source_url: "https://endocrinenews.endocrine.org/society-offers-full-spectrum-of-diabetes-resources-including-a-new-sig-for-diabetes-clinicians-and-researchers/"
published_at: "2026-11-03T12:55:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Endocrine Society Launches Diabetes SIG and Expands Education, Research, Advocacy
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/endocrine-news-1-society-offers-full-spectrum-of-diabetes-resources-including-a-new-sig-for
- **Specialty:** [Endocrinology](https://medichelpline.com/clinical-feed/endocrinology.md)
- **Primary Source:** Endocrine News
- **Source URL:** [Original Journal Publication](https://endocrinenews.endocrine.org/society-offers-full-spectrum-of-diabetes-resources-including-a-new-sig-for-diabetes-clinicians-and-researchers/)
- **Published At:** 2026-11-03T12:55:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The Endocrine Society announced a new **Diabetes SIG** to provide a professional home for clinicians, researchers, educators, and trainees worldwide. - The SIG will host webinars, informal discussions on **EndoForum**, and ongoing opportunities for peer consultation and collaboration across time zones and career stages. - The Society’s education portfolio includes recordings from **Clinical Endocrinology Update (CEU) 2026**, eight diabetes-focused sessions spanning clinical care, pregnancy, technology, and pathogenesis. - A competitive **Type 1 Diabetes Fellows Series** (13th year in 2026) supports trainees; the source stated the 2027 application timing will appear on the fellows webpage but did not provide application dates. - ENDO 2026 programming included pregnancy-focused sessions; the Society plans a new Jesse Roth Award Lecture at **ENDO 2027**, honoring contributions to insulin receptor research. - The Center for Learning hosts conference recordings and stand-alone modules on diabetes topics; the source listed several course titles but did not report participation numbers or accreditation specifics. - Written resources—ESAP 2026, Endocrine Board Review 2026, Meet the Professor 2026—contain numerous diabetes cases and chapters; exact case counts and chapter titles were provided by the source. - Society journals published high-Altmetric diabetes articles in 2026; topics ranged from GLP-1 agonists and fractures to time-in-range associations with microvascular complications. - Advocacy efforts center on insulin affordability, the INSULIN Act, and reauthorization of the **Special Diabetes Program (SDP)**; the source did not report legislative timelines or specific lobbying strategies. - The Society also promotes member engagement through merchandise and community activities; the source did not provide usage metrics or membership uptake data.
## Clinical Analysis & Structured Key Points
[Skip to content](https://endocrinenews.endocrine.org/society-offers-full-spectrum-of-diabetes-resources-including-a-new-sig-for-diabetes-clinicians-and-researchers/#wp--skip-link--target) [Endocrine News](https://endocrinenews.endocrine.org) [![Endocrine News](https://endocrinenews.endocrine.org/wp-content/uploads/es-reversed.svg)](https://endocrinenews.endocrine.org/) * [Topics](https://endocrinenews.endocrine.org/category/health-topic/diabetes/) * [Diabetes](https://endocrinenews.endocrine.org/category/health-topic/diabetes/) * [Obesity](https://endocrinenews.endocrine.org/category/health-topic/obesity/) * [Adrenal](https://endocrinenews.endocrine.org/category/health-topic/adrenal/) * [Bone and Mineral](https://endocrinenews.endocrine.org/category/health-topic/bone-and-mineral/) * [Cardiometabolic](https://endocrinenews.endocrine.org/category/health-topic/cardiometabolic/) * [Endocrine Disruptors](https://endocrinenews.endocrine.org/category/health-topic/endocrine-disruptors/) * [Head Glands](https://endocrinenews.endocrine.org/category/health-topic/head-glands/) * [Kidney Issues](https://endocrinenews.endocrine.org/category/health-topic/kidney-issues/) * [Neoplasia and Cancer](https://endocrinenews.endocrine.org/category/health-topic/neoplasia-and-cancer/) * [Pancreas](https://endocrinenews.endocrine.org/category/health-topic/pancreas/) * [Reproductive Issues](https://endocrinenews.endocrine.org/category/health-topic/reproductive-issues/) * [Thyroid](https://endocrinenews.endocrine.org/category/health-topic/thyroid/) * [Pediatric Health](https://endocrinenews.endocrine.org/category/patient-populations/pediatric-health/) * [Men’s Health](https://endocrinenews.endocrine.org/category/patient-populations/mens-health/) * [Women’s Health](https://endocrinenews.endocrine.org/category/patient-populations/womens-health/) * [Why Endocrinology?](https://endocrinenews.endocrine.org/category/why-endocrinology/) * [Practice](https://endocrinenews.endocrine.org/category/practice/) * [Your Practice](https://endocrinenews.endocrine.org/category/practice/your-practice/) * [Your Patients](https://endocrinenews.endocrine.org/category/practice/your-patients/) * [Product / Technology](https://endocrinenews.endocrine.org/category/practice/product-technology/) * [Endocrinology Workforce](https://endocrinenews.endocrine.org/category/endocrinology-workforce/) * [Lab Notes](https://endocrinenews.endocrine.org/category/lab-notes/) * [Q&A](https://endocrinenews.endocrine.org/category/lab-notes/q-a/) * [Your Laboratory](https://endocrinenews.endocrine.org/category/your-laboratory/) * [Products and Technological Advancements in Endocrinology](https://endocrinenews.endocrine.org/category/lab-notes/products-technology/) * [Advocacy](https://endocrinenews.endocrine.org/category/advocacy/) * [Clinical](https://endocrinenews.endocrine.org/category/advocacy/clinical/) * [Research](https://endocrinenews.endocrine.org/category/advocacy/research/) * [InTouch](https://endocrinenews.endocrine.org/intouch/) * [Member News](https://endocrinenews.endocrine.org/category/in-touch/member-news-in-touch/) * [Society News](https://endocrinenews.endocrine.org/category/in-touch/society-news/) * [Podcast](https://www.endocrine.org/podcast) * [Current Issue Download](https://endocrinenews.endocrine.org/magazine/current-issue/) * [My Profile](https://ams.endocrine.org/eweb/) * [Log In](https://endocrinenews.endocrine.org/auth/login) * [Log Out](https://endocrinenews.endocrine.org/auth/logout) * [Topics](https://endocrinenews.endocrine.org/category/health-topic/diabetes/) * [Diabetes](https://endocrinenews.endocrine.org/category/health-topic/diabetes/) * [Obesity](https://endocrinenews.endocrine.org/category/health-topic/obesity/) * [Adrenal](https://endocrinenews.endocrine.org/category/health-topic/adrenal/) * [Bone and Mineral](https://endocrinenews.endocrine.org/category/health-topic/bone-and-mineral/) * [Cardiometabolic](https://endocrinenews.endocrine.org/category/health-topic/cardiometabolic/) * [Endocrine Disruptors](https://endocrinenews.endocrine.org/category/health-topic/endocrine-disruptors/) * [Head Glands](https://endocrinenews.endocrine.org/category/health-topic/head-glands/) * [Kidney Issues](https://endocrinenews.endocrine.org/category/health-topic/kidney-issues/) * [Neoplasia and Cancer](https://endocrinenews.endocrine.org/category/health-topic/neoplasia-and-cancer/) * [Pancreas](https://endocrinenews.endocrine.org/category/health-topic/pancreas/) * [Reproductive Issues](https://endocrinenews.endocrine.org/category/health-topic/reproductive-issues/) * [Thyroid](https://endocrinenews.endocrine.org/category/health-topic/thyroid/) * [Pediatric Health](https://endocrinenews.endocrine.org/category/patient-populations/pediatric-health/) * [Men’s Health](https://endocrinenews.endocrine.org/category/patient-populations/mens-health/) * [Women’s Health](https://endocrinenews.endocrine.org/category/patient-populations/womens-health/) * [Why Endocrinology?](https://endocrinenews.endocrine.org/category/why-endocrinology/) * [Practice](https://endocrinenews.endocrine.org/category/practice/) * [Your Practice](https://endocrinenews.endocrine.org/category/practice/your-practice/) * [Your Patients](https://endocrinenews.endocrine.org/category/practice/your-patients/) * [Product / Technology](https://endocrinenews.endocrine.org/category/practice/product-technology/) * [Endocrinology Workforce](https://endocrinenews.endocrine.org/category/endocrinology-workforce/) * [Lab Notes](https://endocrinenews.endocrine.org/category/lab-notes/) * [Q&A](https://endocrinenews.endocrine.org/category/lab-notes/q-a/) * [Your Laboratory](https://endocrinenews.endocrine.org/category/your-laboratory/) * [Products and Technological Advancements in Endocrinology](https://endocrinenews.endocrine.org/category/lab-notes/products-technology/) * [Advocacy](https://endocrinenews.endocrine.org/category/advocacy/) * [Clinical](https://endocrinenews.endocrine.org/category/advocacy/clinical/) * [Research](https://endocrinenews.endocrine.org/category/advocacy/research/) * [InTouch](https://endocrinenews.endocrine.org/intouch/) * [Member News](https://endocrinenews.endocrine.org/category/in-touch/member-news-in-touch/) * [Society News](https://endocrinenews.endocrine.org/category/in-touch/society-news/) * [Podcast](https://www.endocrine.org/podcast) * [Current Issue Download](https://endocrinenews.endocrine.org/magazine/current-issue/) * [My Profile](https://ams.endocrine.org/eweb/) * [Log In](https://endocrinenews.endocrine.org/auth/login) * [Log Out](https://endocrinenews.endocrine.org/auth/logout) Search Search [Current Issue Download](https://endocrinenews.endocrine.org/magazine-issues/october-2026/) [Login](https://endocrinenews.endocrine.org/auth/login/?redirect=https://endocrinenews.endocrine.org/society-offers-full-spectrum-of-diabetes-resources-including-a-new-sig-for-diabetes-clinicians-and-researchers/) ![](https://endocrinenews.endocrine.org/wp-content/themes/mg-starter/assets/images/Endocrine_News_standard_logo.svg) * * * # Society Offers Full Spectrum of Diabetes Resources, Including a New SIG for Diabetes Clinicians and Researchers By Nanette Santoro, MD, President, Endocrine Society November 3, 2026 Print this article Share this article ![](https://endocrinenews.endocrine.org/wp-content/uploads/Santoro-Headshot-2025.jpg) November is Diabetes Month in the United States, making this the perfect time to highlight the many resources and initiatives the Society dedicates to this chronic disease state. Diabetes has always been a central feature of the Society’s work. The discovery of insulin therapies just over 100 years ago transformed our field. And today, many of our members dedicate their clinical and research careers to finding new ways of treating diabetes. That’s why I’m delighted to note the Society last month launched the Diabetes Special Interest Group (SIG), essentially creating a professional home for thousands of diabetes clinicians and scientists around the world. The Diabetes SIG will connect endocrinologists, researchers, educators, and trainees who are committed to advancing diabetes research, prevention, and patient care. And like our other SIGs, this one will provide many opportunities throughout the year for members to engage and collaborate. This is done through regularly scheduled webinars, as well as informal discussions on the [**EndoForum platform**](https://endoforum.endocrine.org/page/lobby). Diabetes SIG members will share knowledge, discuss emerging developments, build professional networks, and explore innovations that improve outcomes for people living with diabetes. Always open, the SIG allows members to ask peers for advice or share thoughts at any time and from any location ## **Educational Programs and Activities** As important as this new SIG is, it’s only a small part of what the Society does in the realm of diabetes. Our organization offers a full spectrum of metabolism resources and initiatives. Below are some of them. Many of the Society’s educational programs and meetings focus on diabetes. Recordings will soon be available from the recently concluded [**Clinical Endocrinology Update (CEU) 2026**](https://ceu2026.endocrine.org/?_gl=1*19j4mmp*_gcl_au*MjEwMTk1NDkwNC4xNzg2NTI2Njc3), which provided eight sessions on the topic: 1. Managing Endocrine Complications of Immune Checkpoint Inhibitors: A Multidisciplinary Approach 2. Diabetes in Pregnancy: Optimizing Maternal and Fetal Outcomes 3. Once-Weekly Insulin: Innovations for Less Intervention in Diabetes 4. Balancing for Two: Evidence-Based Care for Diabetes in Pregnancy 5. Challenges and Opportunities for Understanding the Pathogenesis of Type 1 Diabetes: An Endocrine Society Scientific Statement 6. Peripheral Vascular Disease in Diabetes: Screening, Prevention, and Management 7. Intermittent Fasting in Diabetes: Science, Technology, and Patient-Centered Care 8. Diabetes Technology in Practice: Insulin Pumps, CGMs, and Complex Case Management Diabetes also is the topic of our upcoming joint meeting with Keystone: “[**Reimagining Diabetes: From Molecular Mechanisms to Transformative Therapies**](https://www.keystonesymposia.org/conferences/conference-listing/meeting/a32027),” February 1 – 4, 2027, in Keystone, Colo. The meeting is designed to connect basic science, clinical research, and industry to better understand disease drivers and identify new therapeutic strategies. Another exciting educational offering is the competitive [**Type 1 Diabetes Fellows Series**](https://www.endocrine.org/education-and-training/type-1-diabetes-fellows-series). In 2026, the program marked its 13th year providing support to endocrine fellows as they begin their careers as practicing clinicians and diabetes experts. > No matter what aspect of diabetes and metabolism inspires you, we have the resources you need to expand your knowledge and grow your career. I am proud of all the work our members are doing to care for people with diabetes and study this condition. > > During the June program at **ENDO 2026** in Chicago, Ill., Camille Powe, MD, presented a session on how pregnant women with type 1 diabetes are still considered to have high-risk pregnancies, and susceptible to complications such as fetal overgrowth. Powe’s research was the subject of an [**Endocrine News podcast**](https://www.endocrine.org/podcast/enp116-t1d-and-pregnancy). Check back on the [**fellows webpage**](https://www.endocrine.org/education-and-training/type-1-diabetes-fellows-series) for the 2027 application cycle. I’m also pleased to announce the Society will debut a new lecture at **ENDO 2027** named in honor of Jesse Roth, MD. Dr. Roth was a trailblazing endocrinologist whose research on insulin receptors revolutionized our understanding of diabetes. The Jesse Roth Award Lecture will feature a speaker who has made significant clinical and research contributions to endocrinology. The Society provides even more diabetes education online through its [Center for Learning](https://education.endocrine.org/Users/ChefViewCatalog.aspx?Option=198). Offerings include [**conference session recordings**](https://education.endocrine.org/Users/LearningActivity/LearningActivityDetail.aspx?LearningActivityID=yzev6cgI245zK5WT9THyeQ%3d%3d) on diabetes, as well as stand-alone events such as, [**Using Diabetes Technology in Pregnancy**](https://education.endocrine.org/Users/LearningActivityInformation.aspx?LearningActivityID=S9OQ3pzn4zPPmOleCl7Inw%3d%3d), and [**Two Generations, One Challenge: Confronting Obesity in Pregnancy and Childhood’s Metabolic Outcomes**](https://education.endocrine.org/Users/LearningActivityInformation.aspx?LearningActivityID=%2frjlghEoADIi7vkCsSYmQw%3d%3d)**.** Diabetes also is an ever-present topic in our written educational resources. The[**Endocrine Self-Assessment Program (ESAP) 2026**](https://www.endocrine.org/education-and-training/esap) dedicated 30 cases to diabetes. [**Endocrine Board Review (EBR) 2026**](https://www.endocrine.org/store/board-review-products/endocrine-board-review-18th-edition-2026-bundle) provided another 52 cases. And the [**Meet the Professor (MTP) 2026**](https://www.endocrine.org/store/meet-the-professor/meet-the-professor-2026-book-includes-ebook) book included six chapters on diabetes: 1. Updates in the Management of Diabetic Kidney Disease 2. Type 2 Diabetes in Preconception, Pregnancy, and Postpartum 3. Transition of Care in Patients with Youth-Onset Type 2 Diabetes 4. Use of Adjunctive Glucose-Lowering Therapies to Target Cardiometabolic Risk in Type 1 Diabetes 5. Managing Hyperglycemia in Hospitalized Patients 6. GLP-1 Receptor Agonists and Pancreatitis and Pancreatic Lesions: What Is the Evidence and When Are They Contraindicated? Our [**Endocrine Education Cases Flashcards**](https://www.endocrine.org/store/clearance/residency-cards--educational-pocket-guide) include 57 cards on diabetes treatment in a convenient pocket guide for residents, fellows, and clinicians in training. ## **Diabetes Science and Research** Diabetes researchers have long found a welcome publishing home in our [**suite of scientific journals**](https://www.endocrine.org/journals). The Society’s top Altmetric-scoring journal papers published so far in 2026 with “diabetes” as a keyword include: * GLP-1 receptor agonists and the risk of fragility fractures in older adults with type 2 diabetes * Greater reduction in the proinsulin-C-peptide ratio with a ketogenic vs control diet in patients with type 2 diabetes * Social inequalities in gestational diabetes prevalence and complication burden: a nationwide Swedish cohort study * The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults * Association between worsening time in range and microvascular complications in type 1 diabetes: real-world 5-year study. These are the kinds of articles that our journals team gathers for a special thematic issue each year. This year’s April thematic issue, which includes articles from all of our journals, was dedicated to [**Obesity and Metabolic Health: Diet, Exercise, and Appetite Regulation**](https://www.endocrine.org/journals/thematic-issues/obesity-and-metabolic-health). ## **Diabetes Advocacy** Another area where we excel on the diabetes front is advocacy. On Capitol Hill, we are one of the leading voices working to ensure that people living with diabetes have access to affordable insulin. Our sustained efforts in years past have helped pass legislation to lower the cost of insulin for Medicare beneficiaries, and we currently are advocating to lower insulin cost for those on private insurance and the uninsured. In addition, we’re advocating for Congress to reauthorize the Special Diabetes Program (SDP), a vital program that funds type 1 diabetes research and type 2 diabetes education and treatment programs for American Indians and Alaskan Native communities. > Another area where we excel on the diabetes front is advocacy. On Capitol Hill, we are one of the leading voices working to ensure that people living with diabetes have access to affordable insulin. In October, our advocacy team launched its [**Diabetes Advocacy Campaign**](https://secure.everyaction.com/uYPIitH8YUCWTrhdNk7yIw2), to focus on reauthorizing SDP and passing the [**INSULIN Act**](https://www.endocrine.org/news-and-advocacy/news-room/2026/endocrine-society-applauds-introduction-of-bipartisan-bill-to-address-insulin-affordability). Finally, we can’t help but have a little fun with this topic. Our store is full of products that allow our members to proudly display their diabetes bona fides. These include our pancreas socks, [**keychains**](https://www.endocrine.org/store/souvenirs/gland-keychain---pancreas), [**lapel pins**](https://www.endocrine.org/store/souvenirs/gland-lapel-pin--pancreas), and [**plushies**](https://www.endocrine.org/store/souvenirs/gland-plushie--pancreas). No matter what aspect of diabetes and metabolism inspires you, we have the resources you need to expand your knowledge and grow your career. I am proud of all the work our members are doing to care for people with diabetes and study this condition. * * * * * * ## TOPICS IN THIS ARTICLE: [President’s Viewpoint](https://endocrinenews.endocrine.org/category/presidents-viewpoint/) ←[Society Advocates for Diabetes; Urges Congress to Address Diabetes Research and Access to Affordable Insulin](https://endocrinenews.endocrine.org/society-advocates-for-diabetes-urges-congress-to-address-diabetes-research-and-access-to-affordable-insulin/) [The Society Explores the Future of Evidence-Based Guidelines in Italy](https://endocrinenews.endocrine.org/the-society-explores-the-future-of-evidence-based-guidelines-in-italy/)→ ## RELATED ARTICLES * ![Inaugural EndoForum Live 2027 to Present the Best of Society’s SIGs](https://endocrinenews.endocrine.org/wp-content/uploads/Santoro-Headshot-2025.jpg) ### [ Inaugural EndoForum Live 2027 to Present the Best of Society’s SIGs ](https://endocrinenews.endocrine.org/inaugural-endoforum-live-2027-to-present-the-best-of-societys-sigs/) October 15, 2026 * ![New Offerings Demonstrate the Endocrine Society’s Leadership Role in Obesity Space](https://endocrinenews.endocrine.org/wp-content/uploads/Santoro-Headshot-2025.jpg) ### [ New Offerings Demonstrate the Endocrine Society’s Leadership Role in Obesity Space ](https://endocrinenews.endocrine.org/new-offerings-demonstrate-the-endocrine-societys-leadership-role-in-obesity-space/) September 4, 2026 * ![Fall Meetings Offer World-Class Learning for Both Clinicians and Researchers](https://endocrinenews.endocrine.org/wp-content/uploads/Santoro-Headshot-2025.jpg) ### [ Fall Meetings Offer World-Class Learning for Both Clinicians and Researchers ](https://endocrinenews.endocrine.org/fall-meetings-offer-world-class-learning-for-both-clinicians-and-researchers/) August 5, 2026 * * * ADVERTISEMENT ![October 2026](https://endocrinenews.endocrine.org/wp-content/uploads/10.26EndoCover-765x1024.jpg) [View Archives](https://endocrinenews.endocrine.org/magazine-issues/) ADVERTISEMENT ADVERTISEMENT ![](https://endocrinenews.endocrine.org/wp-content/themes/mg-starter/assets/images/scientists_optim-1024x569.jpg) ## Join the Global Movement Advancing Endocrine Science and Medicine Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities. [Join Today](https://www.endo
## Related Clinical Research

- [Undiagnosed type 2 diabetes presenting as DKA with hypertriglyceridemia-induced acute pancreatitis](https://medichelpline.com/clinical-feed/cmaj-1-undiagnosed-type-2-diabetes-presenting-as-diabetic-ketoacidosis-with.md)
- [Resistance exercise preserves lean mass during tirzepatide therapy for obesity](https://medichelpline.com/clinical-feed/nature-1-resistance-exercise-to-attenuate-lean-mass-loss-during-tirzepatide-therapy-for.md)
- [Anticipatory Insulin Secretion Is Disrupted in Obesity and Hyperglycemia](https://medichelpline.com/clinical-feed/medrxiv-7-disruption-of-anticipatory-insulin-secretion-in-patients-with-hyperglycemia-and.md)
- [Safiglipron vs dapagliflozin in type 2 diabetes: phase 3 randomized double-blind OUTSTAND-2 results](https://medichelpline.com/clinical-feed/nature-0-oral-small-molecule-glp-1ra-safiglipron-versus-dapagliflozin-in-type-2-diabetes.md)
- [GLP-1 receptor agonists and PMOS: evidence, mechanisms, and who may benefit](https://medichelpline.com/clinical-feed/medical-news-today-0-can-glp-1s-really-help-treat-pmos-experts-answer-3-key-questions.md)

## Navigation
- [← Back to Endocrinology Feed](https://medichelpline.com/clinical-feed/endocrinology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.